Literature DB >> 20711714

Multidrug therapy in a patient with Rabson-Mendenhall syndrome.

Rodrigo O Moreira, R L Zagury, T S Nascimento, L Zagury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20711714     DOI： 10.1007/s00125-010-1879-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

Review 1.  Genetically defined forms of diabetes in children.

Authors:  S I Taylor; E Arioglu
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

Review 2.  Acquired and inherited lipodystrophies.

Authors:  Abhimanyu Garg
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

3.  A patient with extreme insulin resistance syndrome treated with pioglitazone.

Authors:  Yoshiyuki Hattori; Hiroko Satoh; Takashi Namatame; Sachiko Hattori; Kikuo Kasai
Journal:  Diabetes Care       Date:  2006-10       Impact factor: 19.112

4.  Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.

Authors:  B Charbonnel; G Schernthaner; P Brunetti; D R Matthews; R Urquhart; M H Tan; M Hanefeld
Journal:  Diabetologia       Date:  2005-05-12       Impact factor: 10.122

5.  Substitution of glutamic acid for alanine 1135 in the putative "catalytic loop" of the tyrosine kinase domain of the human insulin receptor. A mutation that impairs proteolytic processing into subunits and inhibits receptor tyrosine kinase activity.

Authors:  A Cama; M de la Luz Sierra; M J Quon; L Ottini; P Gorden; S I Taylor
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

Review 6.  Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective.

Authors:  Carla Musso; Elaine Cochran; Stephanie Ann Moran; Monica C Skarulis; Elif Arioglu Oral; Simeon Taylor; Phillip Gorden
Journal:  Medicine (Baltimore)       Date:  2004-07       Impact factor: 1.889
  6 in total
  5 in total

1.  Clinical and Functional Characterization of Novel INSR Variants in Two Families With Severe Insulin Resistance Syndrome.

Authors:  Qiaoli Zhou; Jing Yu; Xuewen Yuan; Chunli Wang; Ziyang Zhu; Aihua Zhang; Wei Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-29       Impact factor: 5.555

2.  Caenorhabditis elegans DAF-2 as a Model for Human Insulin Receptoropathies.

Authors:  David A Bulger; Tetsunari Fukushige; Sijung Yun; Robert K Semple; John A Hanover; Michael W Krause
Journal:  G3 (Bethesda)       Date:  2017-01-05       Impact factor: 3.154

3.  A Mutation in INSR in a Child Presenting with Severe Acanthosis Nigricans.

Authors:  Hale Tuhan; Serdar Ceylaner; Özlem Nalbantoğlu; Sezer Acar; Ayhan Abacı; Ece Böber; Korcan Demir
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-06-30

Review 4.  Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.

Authors:  Michaela Plamper; Bettina Gohlke; Felix Schreiner; Joachim Woelfle
Journal:  Int J Mol Sci       Date:  2018-04-24       Impact factor: 5.923

5.  Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.

Authors:  José Ignacio Martínez-Montoro; José Luis Pinzón-Martín; Miguel Damas-Fuentes; Andrea Fernández-Valero; Francisco J Tinahones
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.